var tmpLoc = window.location.toString();

tmpLoc.search(/dev.ccit/i) > 0 ? _server="http://dev.ccit.bcm.tmc.edu/lipidsonline" : tmpLoc.search(/staging.ccit/i) > 0 ? _server="http://staging.ccit.bcm.tmc.edu/lipidsonline" : _server="http://www.lipidsonline.org";

scriptpath=_server+"/_menu/";
_isHome==1?_menuTop=131:_menuTop=100;
_globalRawCSS = "rawcss=padding:1px 7px;";

_menuCloseDelay=1300           // The time delay for menus to remain visible on mouse out
_menuOpenDelay=150             // The time delay before menus open on mouse over
closeAllOnClick = true; 

horizontalMenuDelay = true
_followSpeed=5                // Follow scrolling speed
_followRate=40                // Follow scrolling Rate
_subOffsetTop=0               // Sub menu top offset
_subOffsetLeft=-7            // Sub menu left offset
_scrollAmount=3               // Only needed for Netscape 4.x
_scrollDelay=20               // Only needed for Netcsape 4.x


with(menuStyle=new mm_style()){
onbgcolor="#949187";      // the color of the menu items when they are rolled over
oncolor="#FFFFFF";        // the color of the menu text when they are rolled over
offbgcolor="#615F58";     // the color of the menu items not being rolled over
offcolor="#FFFFFF";       // the color of the menu text when not being rolled over
bordercolor="#54534d";
borderstyle="none";
borderwidth=1;
separatorcolor="#7e807d";
separatorsize="0";
padding=3;
fontsize="10px";
fontstyle="normal";
fontfamily="Verdana, Tahoma, Arial";
headercolor="#000000";
headerbgcolor="#ffffff";
subimage=scriptpath+"arrow.gif";
subimagepadding="0";
overfilter="Fade(duration=0.05);Shadow(color='#222222', Direction=135, Strength=5)";
outfilter="randomdissolve(duration=0.05)";
}

topStyle=new copyOf(menuStyle) 
topStyle.subimage="";
topStyle.offbgcolor="#54534d"; 
topStyle.onbgcolor="#87847b"; 

thirdLevel=new copyOf(menuStyle)
thirdLevel.offbgcolor="#6E6C64"; 
thirdLevel.onbgcolor="#a19d92"; 
thirdLevel.itemwidth=270;

fourthLevel=new copyOf(menuStyle)
fourthLevel.offbgcolor="#7A786F";
fourthLevel.onbgcolor="#adaa9e";
fourthLevel.itemwidth=270;

menuStyle.itemwidth=270;




with(milonic=new menuname("Main Menu")){
style=topStyle;
top=_menuTop;
left=0;
alwaysvisible=1;
orientation="horizontal";
overfilter="Fade(duration=0.0);"
aI("text=Home;url="+_server+";"+_globalRawCSS);
aI("text=Slide Library;url="+_server+"/slides;showmenu=Slides;"+_globalRawCSS);
aI("text=Virtual Meetings;url="+_server+"/meetings;showmenu=Meetings;"+_globalRawCSS);
aI("text=Commentaries;url="+_server+"/commentaries;showmenu=Commentaries;"+_globalRawCSS);
aI("text=Cases;url="+_server+"/clinical-cases;showmenu=Cases;"+_globalRawCSS);
aI("text=CME;url="+_server+"/cme;showmenu=CME;"+_globalRawCSS);
aI("text=Lipid Preceptorship;url="+_server+"/vlp;showmenu=vlp;"+_globalRawCSS);
aI("text=News;url="+_server+"/news;showmenu=news;"+_globalRawCSS);
aI("text=Subjects;url="+_server+"/site/subjects.cfm;showmenu=subjects;"+_globalRawCSS);
}

with(milonic=new menuname("Slides")){
style=menuStyle;
aI("text=Overview;url="+_server+"/slides;Status=none;separatorsize=1;separatorpadding=0;"+_globalRawCSS);
aI("text=Clinical Cases;url="+_server+"/slides/index.cfm#cases;showmenu=SlidesCases;"+_globalRawCSS);
aI("text=Cardiometabolic Risk;url="+_server+"/slides/index.cfm#cmr;showmenu=SlidesCmr;"+_globalRawCSS);
aI("text=Evolving Concepts in Lipid Management;url="+_server+"/slides/index.cfm#combination;showmenu=SlidesConcepts;"+_globalRawCSS);
aI("text=Guidelines for Risk Assessment and Management;url="+_server+"/slides/index.cfm#atpiii;showmenu=SlidesATPIII;"+_globalRawCSS);
aI("text=New Evidence and the Guidelines: Is a Revision Needed?;url="+_server+"/slides/index.cfm#newevidence;showmenu=SlidesEvidence;"+_globalRawCSS);
aI("text=Dyslipidemia, Inflammation and Atherosclerosis;url="+_server+"/slides/index.cfm#athero;showmenu=SlidesInflammation;"+_globalRawCSS);
aI("text=Dyslipidemia, Diabetes and CHD;url="+_server+"/slides/index.cfm#chd;showmenu=SlidesDiabetes;"+_globalRawCSS);
aI("text=HDL and Coronary Heart Disease;url="+_server+"/slides/index.cfm#hdl;showmenu=SlidesHDL;separatorsize=1;separatorpadding=0;"+_globalRawCSS);

aI("text=Index of Slide Contents;url="+_server+"/slides/keywords.cfm;"+_globalRawCSS);
aI("text=Slide Library Help;url="+_server+"/slides/howto.cfm;"+_globalRawCSS);
}

with(milonic=new menuname("SlidesCases")){
style=thirdLevel;
aI("text=A Case of Adolescent Obesity: The Role of Bariatric Surgery;url="+_server+"/slides/slide01.cfm?tk=74;"+_globalRawCSS);
aI("text=Consideration of Polypharmacology in Relation to Effective Weight Reduction: A Patient on Antipsychotic Medication;url="+_server+"/slides/slide01.cfm?tk=64;"+_globalRawCSS);
aI("text=Consideration of Polypharmacology in Regards to Effective Weight Reduction: A Patient on Diabetes Medication;url="+_server+"/slides/slide01.cfm?tk=63;"+_globalRawCSS);
aI("text=A Mexican American Woman with Multiple Metabolic Risk Factors;url="+_server+"/slides/slide01.cfm?tk=62;"+_globalRawCSS);
aI("text=Benefits of Moderate Weight Loss in Reducing Cardiometabolic Risk;url="+_server+"/slides/slide01.cfm?tk=48;"+_globalRawCSS);
aI("text=The Patient with Severe Hypertriglyceridemia;url="+_server+"/slides/slide01.cfm?tk=47;"+_globalRawCSS);
aI("text=Management of the Patient with Familial Hypercholesterolemia;url="+_server+"/slides/slide01.cfm?tk=40;"+_globalRawCSS);
aI("text=The Patient with a Statin Intolerance;url="+_server+"/slides/slide01.cfm?tk=36;"+_globalRawCSS);
aI("text=Lipid Treatment and Goal Attainment: A Hispanic Male with CHD and Diabetes;url="+_server+"/slides/slide01.cfm?tk=34;"+_globalRawCSS);

}

with(milonic=new menuname("SlidesCMR")){
style=thirdLevel;
aI("text=Prevention of Diabetes;url="+_server+"/slides/slide01.cfm?tk=61;"+_globalRawCSS);
aI("text=Therapeutic Options for Modifying Cardiovascular and Metabolic Risk Factors;url="+_server+"/slides/slide01.cfm?tk=55;"+_globalRawCSS);
aI("text=Visceral Adipose Tissue and Cardiometabolic Risk: Does It Really Matter? Part 1;url="+_server+"/slides/slide01.cfm?tk=53;"+_globalRawCSS);
aI("text=Visceral Adipose Tissue and Cardiometabolic Risk: Does It Really Matter? Part 2;url="+_server+"/slides/slide01.cfm?tk=54;"+_globalRawCSS);
aI("text=The Biology of the Endocannabinoid System and Its Relation to Obesity;url="+_server+"/slides/slide01.cfm?tk=46;"+_globalRawCSS);
aI("text=Effects of Physical Activity and Exercise on Reducing Risk for Cardiovascular Disease and Diabetes, with a Focus on the Obese Patient;url="+_server+"/slides/slide01.cfm?tk=45;"+_globalRawCSS);
aI("text=The Metabolic Syndrome: Introduction and Definitions;url="+_server+"/slides/slide01.cfm?tk=41;"+_globalRawCSS);
aI("text=Strategies for Lifestyle Modification in the Prevention of Diabetes and Cardiovascular Disease;url="+_server+"/slides/slide01.cfm?tk=43;"+_globalRawCSS);
aI("text=C-Reactive Protein: A Marker of Risk ;url="+_server+"/slides/slide01.cfm?tk=37;"+_globalRawCSS);
aI("text=Epidemiology of Insulin Resistance, Diabetes Mellitus and CHD;url="+_server+"/slides/slide01.cfm?tk=14;"+_globalRawCSS);

}

with(milonic=new menuname("SlidesConcepts")){
style=thirdLevel;
aI("text=Role of Omega-3 Fatty Acids in Cardiovascular Disease Prevention;url="+_server+"/slides/slide01.cfm?tk=42;"+_globalRawCSS);
aI("text=C-Reactive Protein: A Target of Therapy;url="+_server+"/slides/slide01.cfm?tk=38;"+_globalRawCSS);
aI("text=Combination Lipid-Altering Drug Therapy with Statins: An Update;url="+_server+"/slides/slide01.cfm?tk=33;"+_globalRawCSS);
aI("text=Cholesterol Metabolism and the Concept of Dual Inhibition;url="+_server+"/slides/slide01.cfm?tk=31;"+_globalRawCSS);
}

with(milonic=new menuname("SlidesATPIII")){
style=thirdLevel;

aI("text=AHA/ACC Secondary Prevention Guidelines and the Evidence to Support Them;url="+_server+"/slides/slide01.cfm?tk=68;"+_globalRawCSS);
aI("text=Lifestyle Interventions: Dietary Therapy, Physical Activity, Weight Control;url="+_server+"/slides/slide01.cfm?tk=22;"+_globalRawCSS);
aI("text=Selecting Successful Lipid-Lowering Treatments;url="+_server+"/slides/slide01.cfm?tk=23;"+_globalRawCSS);
aI("text=ATP III: New Approaches in Identifying and Treating High-Risk Patients;url="+_server+"/slides/slide01.cfm?tk=24;"+_globalRawCSS);  
}

with(milonic=new menuname("SlidesEvidence")){
style=thirdLevel;
aI("text=Heart Protection Study;url="+_server+"/slides/slide01.cfm?tk=27;"+_globalRawCSS);
}

with(milonic=new menuname("SlidesHDL")){
style=thirdLevel;

aI("text=Coronary Imaging and Coronary Event Trials;url="+_server+"/slides/slide01.cfm?tk=70;"+_globalRawCSS);
aI("text=Current and Emerging Pharmacologic Approaches to Targeting HDL;url="+_server+"/slides/slide01.cfm?tk=71;"+_globalRawCSS);
aI("text=Evidence to Support Aggressive Management of HDL-C: Implications of Recent Trials;url="+_server+"/slides/slide01.cfm?tk=39;"+_globalRawCSS);
aI("text=HDL as a Therapeutic Target;url="+_server+"/slides/slide01.cfm?tk=25;"+_globalRawCSS);
aI("text=Epidemiology of CHD;url="+_server+"/slides/slide01.cfm?tk=9;"+_globalRawCSS);
aI("text=Physiology and Pathophysiology of HDL Metabolism;url="+_server+"/slides/slide01.cfm?tk=10;"+_globalRawCSS);
aI("text=Effects of Lifestyle and Dietary Modification on HDL-C Levels;url="+_server+"/slides/slide01.cfm?tk=12;"+_globalRawCSS);
}

with(milonic=new menuname("SlidesDiabetes")){
style=thirdLevel;
aI("text=Diabetic Dyslipidemia and Atherosclerosis;url="+_server+"/slides/slide01.cfm?tk=17;"+_globalRawCSS);
aI("text=Clinical Trials and Guidelines for Lipid Management in the Diabetic Patient;url="+_server+"/slides/slide01.cfm?tk=15;"+_globalRawCSS);
aI("text=Clinical Evaluation and Nonlipid Treatment of CAD in the Diabetic Patient;url="+_server+"/slides/slide01.cfm?tk=16;"+_globalRawCSS);
}

with(milonic=new menuname("SlidesInflammation")){
style=thirdLevel;
aI("text=Sitosterolemia: A Rare Genetic Disorder Leads to Insight into an Important Physiological Process;url="+_server+"/slides/slide01.cfm?tk=29;"+_globalRawCSS);
aI("text=Inflammatory Markers, Pharmacotherapy and Clinical Trials;url="+_server+"/slides/slide01.cfm?tk=21;"+_globalRawCSS);
aI("text=Inflammation and Pathogenesis of Atherothrombotic Disease;url="+_server+"/slides/slide01.cfm?tk=20;"+_globalRawCSS);
aI("text=Role of Lipoproteins in Inflammation;url="+_server+"/slides/slide01.cfm?tk=18;"+_globalRawCSS);
aI("text=Epidemiology of Inflammatory Markers and CHD: Evidence for High Sensitivity C-Reactive Protein;url="+_server+"/slides/slide01.cfm?tk=19;"+_globalRawCSS);
}

with(milonic=new menuname("SlidesPreceptorship")){
style=thirdLevel;
aI("text=An Introduction to Continuous Quality Improvement;url="+_server+"/slides/slide01.cfm?tk=66;"+_globalRawCSS);
aI("text=Putting Continuous Quality Improvement into Practice at the Marsh Valley Family Clinic;url="+_server+"/slides/slide01.cfm?tk=67;"+_globalRawCSS);
}

with(milonic=new menuname("Meetings")){
style=menuStyle;
aI("text=Overview;url="+_server+"/meetings;Status=none;separatorsize=1;separatorpadding=0;"+_globalRawCSS);
aI("text=A Mandate for Early Intensive Treatment of Abdominal Obesity and Cardiometabolic Risk: Why Weight?;url="+_server+"/meetings/early_treatment;"+_globalRawCSS);
aI("text=Getting Started in the Virtual Lipid Preceptorship;url="+_server+"/meetings/vlp/getting_started;"+_globalRawCSS);
aI("text=The Science of Lipid Management;url="+_server+"/meetings/vlp/science;"+_globalRawCSS);
aI("text=Prevention of Diabetes: Why, How, and When;url="+_server+"/meetings/prev_diabetes;"+_globalRawCSS);

}

with(milonic=new menuname("commentaries")){
style=menuStyle;
aI("text=Overview;url="+_server+"/commentaries;Status=none;separatorsize=1;separatorpadding=0;"+_globalRawCSS);
aI("text=Commentaries on Recent Publications;url="+_server+"/commentaries;showmenu=CommentariesRecent;"+_globalRawCSS);
aI("text=Commentaries Prior to March 2002;url="+_server+"/commentaries;showmenu=CommentariesPrior;"+_globalRawCSS);
aI("text=Commentaries on In-Hospital Initiation of Lipid Regulating Therapy;url="+_server+"/commentaries;showmenu=CommentariesInhospital;"+_globalRawCSS);
}

with(milonic=new menuname("CommentariesRecent")){
style=thirdLevel;

aI("text=Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness (CIMT) in Low Risk Individuals with Subclinical Atherosclerosis: The METEOR Trial;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs059;"+_globalRawCSS);
aI("text=Update on TZDs, Diabetes, and Cardiovascular Disease: Pioglitazone;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs061;"+_globalRawCSS);
aI("text=Update on TZDs, Diabetes, and Cardiovascular Disease: Rosiglitazone;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs060;"+_globalRawCSS);

aI("text=Carotid Intima-Media Thickness in Atherosclerosis Using Pioglitazone (CHICAGO trial);url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs058;"+_globalRawCSS);
aI("text=Reduction of Low-Density Lipoprotein Cholesterol (LDL-C) in Patients with Coronary Heart Disease and Metabolic Syndrome: Analysis of the Treating to New Targets (TNT) Study;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs057;"+_globalRawCSS);
aI("text=The "Weight" of the Evidence Is In: Overweight Is "Widespread" and Deadly;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs056;"+_globalRawCSS);
aI("text=Effect of Very High-intensity Statin Therapy on Regression of Coronary Atherosclerosis: The ASTEROID Trial;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs055;"+_globalRawCSS);
aI("text=Collaborative Atorvastatin Diabetes Study (CARDS);url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs054;"+_globalRawCSS);
aI("text=Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT);url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs049;"+_globalRawCSS);
aI("text=Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL);url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs048;"+_globalRawCSS);
aI("text=The Apo A-I Milano Trial;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs047;"+_globalRawCSS);
aI("text=Coronary Heart Disease Risk in Women's Health Initiative: Updated Analysis;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs046;"+_globalRawCSS);
aI("text=Glycemic Control Slows Rates of Carotid Artery Disease Progression;url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs045;"+_globalRawCSS);
aI("text=The Heart Protection Study (HPS) of Cholesterol Lowering with Simvastatin in Diabetics;url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs044;"+_globalRawCSS);
aI("text=Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA);url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs043;"+_globalRawCSS);
aI("text=C-Reactive Protein, Metabolic Syndrome, and Cardiovascular Events in Women;url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs041;"+_globalRawCSS);
aI("text=AHA/CDC Scientific Statement on C-Reactive Protein and Other Inflammatory Markers;url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs042;"+_globalRawCSS);
aI("text=The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT);url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs039;"+_globalRawCSS);
aI("text=The Bypass Angioplasty Revascularization Investigation (BARI) and Non-High-Density Lipoprotein Cholesterol;url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs040;"+_globalRawCSS);
aI("text=C-Reactive Protein Levels and Risk for First Cardiovascular Events in Women;url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs037;"+_globalRawCSS);
aI("text=Prospective Study of Pravastatin in the Elderly at Risk (PROSPER);url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs038;"+_globalRawCSS);
aI("text=Fluvastatin for Prevention of Cardiac Events Following Successful First PCI;url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs036;"+_globalRawCSS);
aI("text=Early Statin Initiation in Acute Coronary Syndromes;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs035;"+_globalRawCSS);
aI("text=Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women;url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs034;"+_globalRawCSS);
aI("text=Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs033;"+_globalRawCSS);
aI("text=Coronary Heart Disease in Patients with Low LDL-C;url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs031;"+_globalRawCSS);
aI("text=Withdrawal of Statins Increases Event Rates in Patients with Acute Coronary Syndromes;url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs030;"+_globalRawCSS);
}

with(milonic=new menuname("CommentariesPrior")){
style=thirdLevel;
aI("text=Inflammatory Markers and Endothelial Function in Obesity and After Weight Loss;url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs029;"+_globalRawCSS);
aI("text=The Diabetes Prevention Program;url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs018;"+_globalRawCSS);
aI("text=HDL-Atherosclerosis Treatment Study (HATS);url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs024;"+_globalRawCSS);
aI("text=Influence of Low HDL-C and Elevated Triglyceride on CHD Events and Response to Simvastatin in 4S;url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs028;"+_globalRawCSS);
aI("text=Low-Density Lipoprotein Size, Pravastatin Treatment, and Coronary Events;url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs022;"+_globalRawCSS);
aI("text=Effect of Fenofibrate on the Progression of Coronary-Artery Disease in Type 2 Diabetes: the Diabetes Atherosclerosis Intervention Study, a Randomised Study;url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs023;"+_globalRawCSS);
aI("text=Coronary Heart Disease Prediction from Lipoprotein Cholesterol Levels, Triglycerides, Lipoprotein, Apolipoproteins A-I and B, and HDL Density Subfractions: The Atherosclerosis Risk in Communities (ARIC) Study;url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs020;"+_globalRawCSS);
aI("text=Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes. The MIRACL Study: A Randomized Controlled Trial;url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs021;"+_globalRawCSS);
aI("text=Effects of Endurance Exercise Training on Plasma HDL Cholesterol Levels Depend on Levels of Triglycerides: Evidence from Men of the Health, Risk Factors, Exercise Training and Genetics Family Study;url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs019;"+_globalRawCSS);
aI("text=Non-High-Density Lipoprotein Cholesterol as a Predictor of Cardiovascular Disease Mortality;url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs017;"+_globalRawCSS);
aI("text=Effect of Losartan Compared with Captopril on Mortality in Patients with Symptomatic Heart Failure;url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs009;"+_globalRawCSS);
}

with(milonic=new menuname("CommentariesInhospital")){
style=thirdLevel;
aI("text=Use of Lipid-Lowering Medications at Discharge in Patients with Acute Myocardial Infarction: Data from the National Registry of Myocardial Infarction 3;url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs013;"+_globalRawCSS);
aI("text=Usefulness of In-Hospital Prescription of Statin Agents after Angiographic Diagnosis of Coronary Artery Disease in Improving Continued Compliance and Reduced Mortality;url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs014;"+_globalRawCSS);
aI("text=Early Statin Treatment Following Acute Myocardial Infarction and 1-Year Survival;url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs015;"+_globalRawCSS);
aI("text=Beneficial Effects of Pravastatin (±Colestyramine/Niacin) Initiated Immediately after a Coronary Event (the Randomized Lipid-Coronary Artery Disease [L-CAD] Study);url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs016;"+_globalRawCSS);
}

with(milonic=new menuname("cases")){
style=menuStyle;
aI("text=Overview;url="+_server+"/clinical-cases;Status=none;separatorsize=1;separatorpadding=0;"+_globalRawCSS);
aI("text=A Case of Adolescent Obesity: The Role of Bariatric Surgery;url="+_server+"/clinical-cases/adolescent-obesity;"+_globalRawCSS);
aI("text=Consideration of Polypharmacology in Relation to Effective Weight Reduction: A Patient on Antipsychotic Medication;url="+_server+"/clinical-cases/polypharmacology-antipsychotic;"+_globalRawCSS);
aI("text=Consideration of Polypharmacology in Regards to Effective Weight Reduction: A Patient on Diabetes Medication;url="+_server+"/clinical-cases/polypharmacology-diabetes;"+_globalRawCSS);
aI("text=A Mexican American Woman with Multiple Metabolic Risk Factors;url="+_server+"/clinical-cases/mexican-american-woman;"+_globalRawCSS);
aI("text=Benefits of Moderate Weight Loss in Reducing Cardiometabolic Risk;url="+_server+"/clinical-cases/weight-loss;"+_globalRawCSS);
aI("text=The Patient with Severe Hypertriglyceridemia;url="+_server+"/clinical-cases/hypertriglyceridemia;"+_globalRawCSS);
aI("text=Management of the Patient with Familial Hypercholesterolemia;url="+_server+"/clinical-cases/hypercholesterolemia;"+_globalRawCSS);
aI("text=The Patient with a Statin Intolerance;url="+_server+"/clinical-cases/statin-intolerance;"+_globalRawCSS);
aI("text=Lipid Treatment and Goal Attainment: A Hispanic Male with CHD and Diabetes;url="+_server+"/clinical-cases/diabetes;"+_globalRawCSS);

}


with(milonic=new menuname("cme")){
style=menuStyle;
aI("text=Overview;url="+_server+"/cme;Status=none;separatorsize=1;separatorpadding=0;"+_globalRawCSS);
aI("text=Clinical Cases;url="+_server+"/cme;showmenu=CMECases;"+_globalRawCSS);
aI("text=Recent Research;url="+_server+"/cme;showmenu=CMEResearch;"+_globalRawCSS);
aI("text=New Guidelines and New Evidence;url="+_server+"/cme;showmenu=CMEGuidelines;"+_globalRawCSS);
aI("text=Virtual Lipid Preceptorship;url="+_server+"/cme;showmenu=VLP_cme;"+_globalRawCSS);
}




with(milonic=new menuname("VLP_cme")){
style=thirdLevel;
aI("text=Getting Started in the Virtual Lipid Preceptorship;url="+_server+"/meetings/VLP/getting_started;"+_globalRawCSS);
aI("text=The Science of Lipid Management;url="+_server+"/meetings/vlp/science/;"+_globalRawCSS);
aI("text=Continuous Quality Improvement and the PDCA Cycle: Principles and Application;url="+_server+"/meetings/VLP/getting_started;"+_globalRawCSS);
}

with(milonic=new menuname("CMECases")){
style=thirdLevel;
aI("text=A Case of Adolescent Obesity: The Role of Bariatric Surgery;url="+_server+"/clinical-cases/adolescent-obesity;"+_globalRawCSS);
aI("text=Consideration of Polypharmacology in Relation to Effective Weight Reduction: A Patient on Antipsychotic Medication;url="+_server+"/clinical-cases/polypharmacology-antipsychotic;"+_globalRawCSS);
aI("text=Consideration of Polypharmacology in Relation to Effective Weight Reduction: A Patient on Diabetes Medication;url="+_server+"/clinical-cases/polypharmacology-diabetes;"+_globalRawCSS);
aI("text=A Mexican American Woman with Multiple Metabolic Risk Factors;url="+_server+"/clinical-cases/mexican-american-woman;"+_globalRawCSS);
aI("text=Benefits of Moderate Weight Loss in Reducing Cardiometabolic Risk;url="+_server+"/clinical-cases/weight-loss;"+_globalRawCSS);
aI("text=The Patient with Severe Hypertriglyceridemia;url="+_server+"/clinical-cases/hypertriglyceridemia;"+_globalRawCSS);
aI("text=Management of the Patient with Familial Hypercholesterolemia;url="+_server+"/clinical-cases/hypercholesterolemia;"+_globalRawCSS);
aI("text=The Patient with a Statin Intolerance;url="+_server+"/clinical-cases/statin-intolerance;"+_globalRawCSS);
aI("text=Lipid Treatment and Goal Attainment: A Hispanic Male with CHD and Diabetes ;url="+_server+"/clinical-cases/diabetes;"+_globalRawCSS);

}

with(milonic=new menuname("CMEResearch")){
style=thirdLevel;

aI("text=Coronary Imaging and Coronary Event Trials;url="+_server+"/slides/talk_cme_activity.cfm?tk=70&cme_activityid=209&cmepage=cme_info;"+_globalRawCSS);
aI("text=AHA/ACC Secondary Prevention Guidelines and the Evidence to Support Them;url="+_server+"/slides/talk_cme_activity.cfm?tk=68&cme_activityid=208&cmepage=cme_info;"+_globalRawCSS);
aI("text=Current and Emerging Pharmacologic Approaches to Targeting HDL;url="+_server+"/slides/talk_cme_activity.cfm?tk=71&cme_activityid=210&cmepage=cme_info;"+_globalRawCSS);
aI("text=A Mandate for Early Intensive Treatment of Abdominal Obesity and Cardiometabolic Risk: Why Weight?;url="+_server+"/meetings/early_treatment;"+_globalRawCSS);
aI("text=Prevention of Diabetes;url="+_server+"/slides/talk_cme_activity.cfm?tk=061&cme_activityid=186&cmepage=cme_info;"+_globalRawCSS);
aI("text=Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness (CIMT) in Low Risk Individuals with Subclinical Atherosclerosis: The METEOR Trial;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs059&cmepage=cme_info&cme_activityid=187;"+_globalRawCSS);
aI("text=Update on TZDs, Diabetes, and Cardiovascular Disease: Pioglitazone;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs061&cmepage=cme_info;"+_globalRawCSS);
aI("text=Update on TZDs, Diabetes, and Cardiovascular Disease: Rosiglitazone;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs060&cmepage=cme_info;"+_globalRawCSS);
aI("text=Carotid Intima-Media Thickness in Atherosclerosis Using Pioglitazone (CHICAGO trial);url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs058&cmepage=cme_info;"+_globalRawCSS);
aI("text=Reduction of Low-Density Lipoprotein Cholesterol (LDL-C) in Patients with Coronary Heart Disease and Metabolic Syndrome: Analysis of the Treating to New Targets (TNT) Study ;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs057&cmepage=cme_info&cme_activityid=151;"+_globalRawCSS);
aI("text=The "Weight" of the Evidence Is In: Overweight Is "Widespread" and Deadly ;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs056&cmepage=cme_info&cme_activityid=145;"+_globalRawCSS);
aI("text=Prevention of Diabetes: Why, How, and When;url="+_server+"/meetings/prev_diabetes;"+_globalRawCSS);
aI("text=Effect of Very High-intensity Statin Therapy on Regression of Coronary Atherosclerosis: The ASTEROID Trial;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs055&cmepage=cme_info&cme_activityid=122;"+_globalRawCSS);
aI("text=The Heart Protection Study (HPS) of Cholesterol Lowering with Simvastatin in Diabetics;url="+_server+"/commentaries/abs_cme.cfm?cme_id=65&show=info;"+_globalRawCSS);
aI("text=The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT);url="+_server+"/commentaries/abs_cme.cfm?cme_id=5&show=info;"+_globalRawCSS);
aI("text=The Bypass Angioplasty Revascularization Investigation (BARI) and Non-High-Density Lipoprotein Cholesterol;url="+_server+"/commentaries/abs_cme.cfm?cme_id=6&show=info;"+_globalRawCSS);
}



with(milonic=new menuname("CMEGuidelines")){
style=thirdLevel;
aI("text=Therapeutic Options for Modifying Cardiovascular and Metabolic Risk Factors;url="+_server+"/slides/talk_cme_activity.cfm?tk=55&cmepage=cme_info;"+_globalRawCSS);
aI("text=Visceral Adipose Tissue and Cardiometabolic Risk: Does It Really Matter?;url="+_server+"/slides/talk_cme_activity.cfm?tk=53&cmepage=cme_info;"+_globalRawCSS);
aI("text=The Biology of the Endocannabinoid System and Its Relation to Obesity;url="+_server+"/slides/talk_cme_activity.cfm?tk=46&cmepage=cme_info;"+_globalRawCSS);
aI("text=Effects of Physical Activity and Exercise on Reducing Risk for Cardiovascular Disease and Diabetes, with a Focus on the Obese Patient;url="+_server+"/slides/talk_cme_activity.cfm?tk=45&cmepage=cme_info;"+_globalRawCSS);
aI("text=Strategies for Lifestyle Modification in the Prevention of Diabetes and Cardiovascular Disease;url="+_server+"/slides/talk_cme_activity.cfm?tk=43&cmepage=cme_info;"+_globalRawCSS);
aI("text=Modifying Cardiovascular and Metabolic Risk Factors: The Role of the Endocannabinoid System (An Educational Program for Primary Care Providers);url="+_server+"/meetings/metabolic_risk;"+_globalRawCSS);
aI("text=Role of Omega-3 Fatty Acids in Cardiovascular Disease Prevention;url="+_server+"/slides/talk_cme_activity.cfm?tk=42&cmepage=cme_info;"+_globalRawCSS);

aI("text=The Metabolic Syndrome: Introduction and Definitions;url="+_server+"/slides/talk_cme_activity.cfm?tk=41&cmepage=cme_info;"+_globalRawCSS);
} 

with(milonic=new menuname("vlp")){
style=menuStyle;
aI("text=Overview;url="+_server+"/vlp;Status=none;separatorsize=1;separatorpadding=0;"+_globalRawCSS);
aI("text=Module 1: An Introduction to Lipid Management and Continuous Improvement;url="+_server+"/vlp/index_mod1.cfm;showmenu=vlp_mod1;"+_globalRawCSS);
aI("text=Module 2: Applying Continuous Quality Improvement Principles to Lipid Management;url="+_server+"/vlp/index_mod2.cfm;"+_globalRawCSS);

}


with(milonic=new menuname("vlp_mod1")){
style=thirdLevel;
aI("text=Overview;url="+_server+"/vlp/index_mod1.cfm;Status=none;separatorsize=1;separatorpadding=0;"+_globalRawCSS);
aI("text=Getting Started in the Virtual Lipid Preceptorship;url="+_server+"/meetings/vlp/getting%5Fstarted/;"+_globalRawCSS);
aI("text=The 'Science' of Lipid Management;url="+_server+"/meetings/vlp/science/;"+_globalRawCSS);
aI("text=Strategies for Lifestyle Modification in the Prevention of Diabetes and Cardiovascular Disease;url="+_server+"/slides/talk_cme_activity.cfm?tk=43&cmepage=cme_info;"+_globalRawCSS);
aI("text=Effects of Physical Activity and Exercise on Reducing Risk for Cardiovascular Disease and Diabetes, with a Focus on the Obese Patient;url="+_server+"/slides/talk_cme_activity.cfm?tk=45&cmepage=cme_info;"+_globalRawCSS);
aI("text=Benefits of Moderate Weight Loss in Reducing Cardiometabolic Risk;url="+_server+"/clinical%2Dcases/weight%2Dloss/;"+_globalRawCSS);
aI("text=The Patient with Statin Intolerance;url="+_server+"/clinical%2Dcases/statin%2Dintolerance/;"+_globalRawCSS);
}

with(milonic=new menuname("vlp_mod2")){
style=thirdLevel;
aI("text=Continuous Quality Improvement and the PDCA Cycle: Principles and Application;url="+_server+"/vlp/quality_improvement/index.cfm;"+_globalRawCSS);
aI("text=Practice Assessment Using the Lipid Practice Audit Tool;url="+_server+"/vlp/audit_cycle_1/index.cfm;"+_globalRawCSS);
}



with(milonic=new menuname("news")){
style=menuStyle;
aI("text=View News by Date;url="+_server+"/news;"+_globalRawCSS);
aI("text=View News by Subject;url="+_server+"/news/index.cfm?subject=all;Status=none;separatorsize=1;separatorpadding=0;"+_globalRawCSS);
aI("text=Cardiometabolic risk higher in male than female adolescents (Circulation 2008; 117: 2361-2368);url="+_server+"/news/article.cfm?aid=6318;"+_globalRawCSS);
aI("text=Small dense LDL most susceptible to glycation (Atherosclerosis 2008; Advance online publication);url="+_server+"/news/article.cfm?aid=6319;"+_globalRawCSS);
aI("text=    IL1RN variants are associated with high levels CRP, fibrinogen and IL-6 (Arterioscler Thromb Vasc Biol 2008; Advance Online Publication);url="+_server+"/news/article.cfm?aid=6320;"+_globalRawCSS);
aI("text=Carotid bruits predict MI, cardiovascular death (Lancet 2008; 371: 1587-1594);url="+_server+"/news/article.cfm?aid=6323;"+_globalRawCSS);
aI("text=Serum visfatin reduced after weight loss in obese individuals (Nutrition 2008; 24: 517-521);url="+_server+"/news/article.cfm?aid=6312;"+_globalRawCSS);
aI("text=n3 PUFA intake inversely associates with CRP in young Japanese women (Nutr Res 2008; 28: 309-314);url="+_server+"/news/article.cfm?aid=6313;"+_globalRawCSS);
aI("text=    MC4R variants linked to obesity, waist circumference, insulin resistance (Nat Genet 2008; Advance online publication);url="+_server+"/news/article.cfm?aid=6314;"+_globalRawCSS);
aI("text=Longer menstrual cycle associated with unfavorable lipid profile (Nutr Metab Cardiovasc Dis 2008; Advance online publication);url="+_server+"/news/article.cfm?aid=6306;"+_globalRawCSS);
aI("text=Oxidized LDL-induced aldose reductase activity increased during foam cell formation (Arterioscler Thromb Vasc Biol 2008; Advance online publication);url="+_server+"/news/article.cfm?aid=6307;"+_globalRawCSS);
aI("text=High intra-abdominal fat in adolescence increases cardiometabolic risk (Arch Pediatr Adolesc Med 2008; 162: 453-461);url="+_server+"/news/article.cfm?aid=6308;"+_globalRawCSS);

} 

with(milonic=new menuname("subjects")){
style=menuStyle;
aI("text=Cardiometabolic Risk;url="+_server+"/site/subjects.cfm?sid=2;showmenu=Cardiometabolic Risk;"+_globalRawCSS);
aI("text=Cardiovascular Disease;url="+_server+"/site/subjects.cfm?sid=13;showmenu=Cardiovascular Disease;"+_globalRawCSS);
aI("text=Cholesterol Metabolism/Absorption;url="+_server+"/site/subjects.cfm?sid=49;showmenu=Cholesterol Metabolism/Absorption;"+_globalRawCSS);
aI("text=Clinical Trials;url="+_server+"/site/subjects.cfm?sid=50;showmenu=Clinical Trials;"+_globalRawCSS);
aI("text=Diabetes Mellitus;url="+_server+"/site/subjects.cfm?sid=1;showmenu=Diabetes Mellitus;"+_globalRawCSS);
aI("text=Drug Therapy;url="+_server+"/site/subjects.cfm?sid=3;showmenu=Drug Therapy;"+_globalRawCSS);
aI("text=Guidelines/Physician Practice/Tools;url="+_server+"/site/subjects.cfm?sid=4;showmenu=Guidelines/Physician Practice/Tools;"+_globalRawCSS);
aI("text=Inflammation;url="+_server+"/site/subjects.cfm?sid=5;showmenu=Inflammation;"+_globalRawCSS);
aI("text=Lifestyle Therapy;url="+_server+"/site/subjects.cfm?sid=6;showmenu=Lifestyle Therapy;"+_globalRawCSS);
aI("text=Lipoproteins/Triglycerides;url="+_server+"/site/subjects.cfm?sid=7;showmenu=Lipoproteins/Triglycerides;"+_globalRawCSS);
aI("text=Markers;url="+_server+"/site/subjects.cfm?sid=8;showmenu=Markers;"+_globalRawCSS);
aI("text=Receptors;url="+_server+"/site/subjects.cfm?sid=10;showmenu=Receptors;"+_globalRawCSS);
aI("text=Risk Assessment;url="+_server+"/site/subjects.cfm?sid=11;showmenu=Risk Assessment;"+_globalRawCSS);
aI("text=Surgical Therapy;url="+_server+"/site/subjects.cfm?sid=44;showmenu=Surgical Therapy;"+_globalRawCSS);
aI("text=Vascular Endothelium;url="+_server+"/site/subjects.cfm?sid=45;showmenu=Vascular Endothelium;"+_globalRawCSS);
aI("text=Virtual Lipid Preceptorship ;url="+_server+"/site/subjects.cfm?sid=64;showmenu=Virtual Lipid Preceptorship ;"+_globalRawCSS);
aI("text=Women and Special Populations;url="+_server+"/site/subjects.cfm?sid=12;showmenu=Women and Special Populations;"+_globalRawCSS);

} 



with(milonic=new menuname("Cardiometabolic Risk")){
style=thirdLevel;

aI("text=Consideration of Polypharmacology in Regards to Effective Weight Reduction: A Patient on Diabetes Medication;url="+_server+"/clinical-cases/polypharmacology-diabetes;"+_globalRawCSS);
aI("text=Consideration of Polypharmacology in Relation to Effective Weight Reduction: A Patient on Antipsychotic Medication;url="+_server+"/clinical-cases/polypharmacology-antipsychotic;"+_globalRawCSS);
aI("text=A Mandate for Early Intensive Treatment of Abdominal Obesity and Cardiometabolic Risk: Why Weight?;url="+_server+"/meetings/early_treatment;"+_globalRawCSS);
aI("text=A Mexican American Woman with Multiple Metabolic Risk Factors;url="+_server+"/clinical-cases/mexican-american-woman;"+_globalRawCSS);aI("text=More;url="+_server+"/site/subjects.cfm?sid=2;"+_globalRawCSS); 
}
with(milonic=new menuname("Cardiovascular Disease")){
style=thirdLevel;
aI("text=Acute Coronary Syndrome;url="+_server+"/site/subjects.cfm?sid=23;showmenu=Acute Coronary Syndrome;"+_globalRawCSS); aI("text=Atherosclerosis/Arteriosclerosis;url="+_server+"/site/subjects.cfm?sid=14;showmenu=Atherosclerosis/Arteriosclerosis;"+_globalRawCSS); aI("text=Carotid Artery Disease;url="+_server+"/site/subjects.cfm?sid=15;showmenu=Carotid Artery Disease;"+_globalRawCSS); aI("text=Dyslipidemia;url="+_server+"/site/subjects.cfm?sid=18;showmenu=Dyslipidemia;"+_globalRawCSS); aI("text=Hypercholesterolemia;url="+_server+"/site/subjects.cfm?sid=20;showmenu=Hypercholesterolemia;"+_globalRawCSS); aI("text=Hyperlipidemia;url="+_server+"/site/subjects.cfm?sid=21;showmenu=Hyperlipidemia;"+_globalRawCSS); 
}
with(milonic=new menuname("Cholesterol Metabolism/Absorption")){
style=thirdLevel;

aI("text=Combination Lipid-altering Drug Therapy with Statins: An Update;url="+_server+"/slides/slide01.cfm?tk=33;"+_globalRawCSS);
aI("text=Cholesterol Metabolism and the Concept of Dual Inhibition;url="+_server+"/slides/slide01.cfm?tk=31;"+_globalRawCSS);
aI("text=The Bypass Angioplasty Revascularization Investigation (BARI) and NonHigh-Density Lipoprotein Cholesterol;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs040;"+_globalRawCSS);
aI("text=Sitosterolemia: A Rare Genetic Disorder Leads to Insight into an Important Physiological Process;url="+_server+"/slides/slide01.cfm?tk=29;"+_globalRawCSS);aI("text=More;url="+_server+"/site/subjects.cfm?sid=49;"+_globalRawCSS); 
}
with(milonic=new menuname("Clinical Trials")){
style=thirdLevel;

aI("text=Coronary Imaging and Coronary Event Trials;url="+_server+"/slides/slide01.cfm?tk=70;"+_globalRawCSS);
aI("text=AHA/ACC Secondary Prevention Guidelines and the Evidence to Support Them;url="+_server+"/slides/slide01.cfm?tk=68;"+_globalRawCSS);
aI("text=Reduction of Low-Density Lipoprotein Cholesterol in Patients with Coronary Heart Disease and Metabolic Syndrome: Analysis of the Treating to New Targets (TNT) Study;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs057;"+_globalRawCSS);
aI("text=Effect of Very High-intensity Statin Therapy on Regression of Coronary Atherosclerosis: The ASTEROID Trial ;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs055;"+_globalRawCSS);aI("text=More;url="+_server+"/site/subjects.cfm?sid=50;"+_globalRawCSS); 
}
with(milonic=new menuname("Diabetes Mellitus")){
style=thirdLevel;

aI("text=Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness (CIMT) in Low Risk Individuals with Subclinical Atherosclerosis: The METEOR Trial;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs059;"+_globalRawCSS);
aI("text=Prevention of Diabetes;url="+_server+"/slides/slide01.cfm?tk=61;"+_globalRawCSS);
aI("text=Update on TZDs, Diabetes, and Cardiovascular Disease: Pioglitazone;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs061;"+_globalRawCSS);
aI("text=Update on TZDs, Diabetes, and Cardiovascular Disease: Rosiglitazone;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs060;"+_globalRawCSS);aI("text=More;url="+_server+"/site/subjects.cfm?sid=1;"+_globalRawCSS); 
}
with(milonic=new menuname("Drug Therapy")){
style=thirdLevel;
aI("text=Anticholesterolemic Agents;url="+_server+"/site/subjects.cfm?sid=34;showmenu=Anticholesterolemic Agents;"+_globalRawCSS); aI("text=Antihypertensive Agents;url="+_server+"/site/subjects.cfm?sid=31;showmenu=Antihypertensive Agents;"+_globalRawCSS); aI("text=Antiinflammatory Agents;url="+_server+"/site/subjects.cfm?sid=32;showmenu=Antiinflammatory Agents;"+_globalRawCSS); aI("text=Antilipidemic Agents;url="+_server+"/site/subjects.cfm?sid=35;showmenu=Antilipidemic Agents;"+_globalRawCSS); aI("text=Combination Therapy;url="+_server+"/site/subjects.cfm?sid=33;showmenu=Combination Therapy;"+_globalRawCSS); aI("text=Estrogen;url="+_server+"/site/subjects.cfm?sid=38;showmenu=Estrogen;"+_globalRawCSS); aI("text=Fibric Acid Derivatives;url="+_server+"/site/subjects.cfm?sid=28;showmenu=Fibric Acid Derivatives;"+_globalRawCSS); aI("text=HMG-COA Reductase Inhibitors;url="+_server+"/site/subjects.cfm?sid=29;showmenu=HMG-COA Reductase Inhibitors;"+_globalRawCSS); aI("text=Hypoglycemic Agents;url="+_server+"/site/subjects.cfm?sid=36;showmenu=Hypoglycemic Agents;"+_globalRawCSS); aI("text=Insulin;url="+_server+"/site/subjects.cfm?sid=37;showmenu=Insulin;"+_globalRawCSS); 
}
with(milonic=new menuname("Guidelines/Physician Practice/Tools")){
style=thirdLevel;

aI("text=AHA/ACC Secondary Prevention Guidelines and the Evidence to Support Them;url="+_server+"/slides/slide01.cfm?tk=68;"+_globalRawCSS);
aI("text=Achieving Current and Future LDL-C Targets in Daily Practice;url="+_server+"/meetings/daily_practice;"+_globalRawCSS);
aI("text=AHA/CDC Scientific Statement on C-Reactive Protein and Other Inflammatory Markers;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs042;"+_globalRawCSS);
aI("text=ATP III:  New Approaches in Identifying and Treating High-Risk Patients;url="+_server+"/slides/slide01.cfm?tk=24;"+_globalRawCSS);aI("text=More;url="+_server+"/site/subjects.cfm?sid=4;"+_globalRawCSS); 
}
with(milonic=new menuname("Inflammation")){
style=thirdLevel;

aI("text=AHA/CDC Scientific Statement on C-Reactive Protein and Other Inflammatory Markers;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs042;"+_globalRawCSS);
aI("text=Inflammatory Markers and Endothelial Function in Obesity and After Weight Loss;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs029;"+_globalRawCSS);
aI("text=Inflammatory Markers, Pharmacotherapy, and Clinical Trials;url="+_server+"/slides/slide01.cfm?tk=21;"+_globalRawCSS);
aI("text=Inflammation and the Pathogenesis of Atherothrombotic Disease;url="+_server+"/slides/slide01.cfm?tk=20;"+_globalRawCSS);aI("text=More;url="+_server+"/site/subjects.cfm?sid=5;"+_globalRawCSS); 
}
with(milonic=new menuname("Lifestyle Therapy")){
style=thirdLevel;

aI("text=Benefits of Moderate Weight Loss in Reducing Cardiometabolic Risk;url="+_server+"/clinical-cases/weight-loss;"+_globalRawCSS);
aI("text=Prevention of Diabetes: Why, How, and When;url="+_server+"/meetings/prev_diabetes;"+_globalRawCSS);
aI("text=Effects of Physical Activity and Exercise on Reducing Risk for Cardiovascular Disease and Diabetes, with a Focus on the Obese Patient;url="+_server+"/slides/slide01.cfm?tk=45;"+_globalRawCSS);
aI("text=Strategies for Lifestyle Modification in the Prevention of Diabetes and Cardiovascular Disease;url="+_server+"/slides/slide01.cfm?tk=43;"+_globalRawCSS);aI("text=More;url="+_server+"/site/subjects.cfm?sid=6;"+_globalRawCSS); 
}
with(milonic=new menuname("Lipoproteins/Triglycerides")){
style=thirdLevel;
aI("text=Apolipoproteins;url="+_server+"/site/subjects.cfm?sid=43;showmenu=Apolipoproteins;"+_globalRawCSS); aI("text=HDL;url="+_server+"/site/subjects.cfm?sid=40;showmenu=HDL;"+_globalRawCSS); aI("text=LDL;url="+_server+"/site/subjects.cfm?sid=39;showmenu=LDL;"+_globalRawCSS); aI("text=Triglycerides;url="+_server+"/site/subjects.cfm?sid=42;showmenu=Triglycerides;"+_globalRawCSS); aI("text=VLDL;url="+_server+"/site/subjects.cfm?sid=41;showmenu=VLDL;"+_globalRawCSS); 
}
with(milonic=new menuname("Markers")){
style=thirdLevel;

aI("text=C-Reactive Protein: A Marker of Risk;url="+_server+"/slides/slide01.cfm?tk=37;"+_globalRawCSS);
aI("text=C-Reactive Protein: A Target of Therapy;url="+_server+"/slides/slide01.cfm?tk=38;"+_globalRawCSS);
aI("text=AHA/CDC Scientific Statement on C-Reactive Protein and Other Inflammatory Markers;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs042;"+_globalRawCSS);
aI("text=C-Reactive Protein, Metabolic Syndrome, and Cardiovascular Events in Women;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs041;"+_globalRawCSS);aI("text=More;url="+_server+"/site/subjects.cfm?sid=8;"+_globalRawCSS); 
}
with(milonic=new menuname("Receptors")){
style=thirdLevel;

aI("text=Combination Lipid-altering Drug Therapy with Statins: An Update;url="+_server+"/slides/slide01.cfm?tk=33;"+_globalRawCSS);
aI("text=Cholesterol Metabolism and the Concept of Dual Inhibition;url="+_server+"/slides/slide01.cfm?tk=31;"+_globalRawCSS);
aI("text=Inflammatory Markers, Pharmacotherapy, and Clinical Trials;url="+_server+"/slides/slide01.cfm?tk=21;"+_globalRawCSS);
aI("text=Inflammation and the Pathogenesis of Atherothrombotic Disease;url="+_server+"/slides/slide01.cfm?tk=20;"+_globalRawCSS); 
}
with(milonic=new menuname("Risk Assessment")){
style=thirdLevel;

aI("text=Consideration of Polypharmacology in Regards to Effective Weight Reduction: A Patient on Diabetes Medication;url="+_server+"/clinical-cases/polypharmacology-diabetes;"+_globalRawCSS);
aI("text=Consideration of Polypharmacology in Relation to Effective Weight Reduction: A Patient on Antipsychotic Medication;url="+_server+"/clinical-cases/polypharmacology-antipsychotic;"+_globalRawCSS);
aI("text=AHA/ACC Secondary Prevention Guidelines and the Evidence to Support Them;url="+_server+"/slides/slide01.cfm?tk=68;"+_globalRawCSS);
aI("text=A Mexican American Woman with Multiple Metabolic Risk Factors;url="+_server+"/clinical-cases/mexican-american-woman;"+_globalRawCSS);aI("text=More;url="+_server+"/site/subjects.cfm?sid=11;"+_globalRawCSS); 
}
with(milonic=new menuname("Surgical Therapy")){
style=thirdLevel;

aI("text=Fluvastatin for Prevention of Cardiac Events Following Successful First PCI;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs036;"+_globalRawCSS);
aI("text=The Bypass Angioplasty Revascularization Investigation (BARI) and NonHigh-Density Lipoprotein Cholesterol;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs040;"+_globalRawCSS); 
}
with(milonic=new menuname("Vascular Endothelium")){
style=thirdLevel;

aI("text=Inflammatory Markers and Endothelial Function in Obesity and After Weight Loss;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs029;"+_globalRawCSS); 
}
with(milonic=new menuname("Virtual Lipid Preceptorship ")){
style=thirdLevel;

aI("text=An Introduction to Continuous Quality Improvement;url="+_server+"/slides/slide01.cfm?tk=66;"+_globalRawCSS);
aI("text=Putting Continuous Quality Improvement Into Practice at the Marsh Valley Family Clinic;url="+_server+"/slides/slide01.cfm?tk=67;"+_globalRawCSS);
aI("text=Getting Started in the Virtual Lipid Preceptorship;url="+_server+"/meetings/vlp/getting_started;"+_globalRawCSS);
aI("text=The Science of Lipid Management;url="+_server+"/meetings/vlp/science/;"+_globalRawCSS); 
}
with(milonic=new menuname("Women and Special Populations")){
style=thirdLevel;
aI("text=Hispanics;url="+_server+"/site/subjects.cfm?sid=46;showmenu=Hispanics;"+_globalRawCSS); aI("text=Women;url="+_server+"/site/subjects.cfm?sid=47;showmenu=Women;"+_globalRawCSS); 
} with(milonic=new menuname("Acute Coronary Syndrome")){
style=fourthLevel;
openstyle="rtl";
subimage=scriptpath+"arrow_left.gif";
aI("text=Withdrawal of Statins Increases Event Rates in Patients with Acute Coronary Syndromes;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs030;"+_globalRawCSS); aI("text=Early Statin Initiation in Acute Coronary Syndromes;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs035;"+_globalRawCSS); aI("text=Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes. The MIRACL Study: A Randomized Controlled Trial;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs021;"+_globalRawCSS); 
}with(milonic=new menuname("Atherosclerosis/Arteriosclerosis")){
style=fourthLevel;
openstyle="rtl";
subimage=scriptpath+"arrow_left.gif";
aI("text=AHA/ACC Secondary Prevention Guidelines and the Evidence to Support Them;url="+_server+"/slides/slide01.cfm?tk=68;"+_globalRawCSS); aI("text=Effect of Very High-intensity Statin Therapy on Regression of Coronary Atherosclerosis: The ASTEROID Trial ;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs055;"+_globalRawCSS); aI("text=Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL);url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs048;"+_globalRawCSS); aI("text=Prospective Study of Pravastatin in the Elderly at Risk (PROSPER);url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs038;"+_globalRawCSS); aI("text=More;url="+_server+"/site/subjects.cfm?sid=14;"+_globalRawCSS); 
}with(milonic=new menuname("Carotid Artery Disease")){
style=fourthLevel;
openstyle="rtl";
subimage=scriptpath+"arrow_left.gif";
aI("text=Glycemic Control Slows Rates of Carotid Artery Disease Progression;url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs045;"+_globalRawCSS); aI("text=Fluvastatin for Prevention of Cardiac Events Following Successful First PCI;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs036;"+_globalRawCSS); aI("text=Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial – the Losartan Heart Failure Survival Study ELITE II.;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs009;"+_globalRawCSS); aI("text=Inflammatory Markers and Endothelial Function in Obesity and After Weight Loss;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs029;"+_globalRawCSS); aI("text=More;url="+_server+"/site/subjects.cfm?sid=15;"+_globalRawCSS); 
}with(milonic=new menuname("Dyslipidemia")){
style=fourthLevel;
openstyle="rtl";
subimage=scriptpath+"arrow_left.gif";
aI("text=Diabetic Dyslipidemia and Atherosclerosis;url="+_server+"/slides/slide01.cfm?tk=17;"+_globalRawCSS); 
}with(milonic=new menuname("Hypercholesterolemia")){
style=fourthLevel;
openstyle="rtl";
subimage=scriptpath+"arrow_left.gif";
aI("text=Management of the Patient with Familial Hypercholesterolemia;url="+_server+"/clinical-cases/hypercholesterolemia;"+_globalRawCSS); aI("text=Sitosterolemia: A Rare Genetic Disorder Leads to Insight into an Important Physiological Process;url="+_server+"/slides/slide01.cfm?tk=29;"+_globalRawCSS); aI("text=Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: data from the National Registry of Myocardial Infarction 3;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs013;"+_globalRawCSS); 
}with(milonic=new menuname("Hyperlipidemia")){
style=fourthLevel;
openstyle="rtl";
subimage=scriptpath+"arrow_left.gif";
aI("text=Consideration of Polypharmacology in Regards to Effective Weight Reduction: A Patient on Diabetes Medication;url="+_server+"/clinical-cases/polypharmacology-diabetes;"+_globalRawCSS); aI("text=Consideration of Polypharmacology in Relation to Effective Weight Reduction: A Patient on Antipsychotic Medication;url="+_server+"/clinical-cases/polypharmacology-antipsychotic;"+_globalRawCSS); aI("text=A Mexican American Woman with Multiple Metabolic Risk Factors;url="+_server+"/clinical-cases/mexican-american-woman;"+_globalRawCSS); aI("text=The Patient with Severe Hypertriglyceridemia;url="+_server+"/clinical-cases/hypertriglyceridemia;"+_globalRawCSS); aI("text=More;url="+_server+"/site/subjects.cfm?sid=21;"+_globalRawCSS); 
} with(milonic=new menuname("Anticholesterolemic Agents")){
style=fourthLevel;
openstyle="rtl";
subimage=scriptpath+"arrow_left.gif";
aI("text=Evidence to Support Aggressive Management of HDL-C: Implications of Recent Trials;url="+_server+"/slides/slide01.cfm?tk=39;"+_globalRawCSS); aI("text=Combination Lipid-altering Drug Therapy with Statins: An Update;url="+_server+"/slides/slide01.cfm?tk=33;"+_globalRawCSS); aI("text=Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT);url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs049;"+_globalRawCSS); aI("text=Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL);url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs048;"+_globalRawCSS); aI("text=More;url="+_server+"/site/subjects.cfm?sid=34;"+_globalRawCSS); 
}with(milonic=new menuname("Antihypertensive Agents")){
style=fourthLevel;
openstyle="rtl";
subimage=scriptpath+"arrow_left.gif";
aI("text=The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT);url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs039;"+_globalRawCSS); aI("text=Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial – the Losartan Heart Failure Survival Study ELITE II.;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs009;"+_globalRawCSS); 
}with(milonic=new menuname("Antiinflammatory Agents")){
style=fourthLevel;
openstyle="rtl";
subimage=scriptpath+"arrow_left.gif";
aI("text=Inflammatory Markers, Pharmacotherapy, and Clinical Trials;url="+_server+"/slides/slide01.cfm?tk=21;"+_globalRawCSS); 
}with(milonic=new menuname("Antilipidemic Agents")){
style=fourthLevel;
openstyle="rtl";
subimage=scriptpath+"arrow_left.gif";
aI("text=Reduction of Low-Density Lipoprotein Cholesterol in Patients with Coronary Heart Disease and Metabolic Syndrome: Analysis of the Treating to New Targets (TNT) Study;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs057;"+_globalRawCSS); aI("text=Combination Lipid-altering Drug Therapy with Statins: An Update;url="+_server+"/slides/slide01.cfm?tk=33;"+_globalRawCSS); aI("text=Anglo-Scandinavian Cardiac Outcomes Trial – Lipid Lowering Arm (ASCOT-LLA);url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs043;"+_globalRawCSS); aI("text=The Heart Protection Study (HPS) of Cholesterol Lowering with Simvastatin in Diabetics;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs044;"+_globalRawCSS); aI("text=More;url="+_server+"/site/subjects.cfm?sid=35;"+_globalRawCSS); 
}with(milonic=new menuname("Combination Therapy")){
style=fourthLevel;
openstyle="rtl";
subimage=scriptpath+"arrow_left.gif";
aI("text=Management of the Patient with Familial Hypercholesterolemia;url="+_server+"/clinical-cases/hypercholesterolemia;"+_globalRawCSS); aI("text=Combination Lipid-altering Drug Therapy with Statins: An Update;url="+_server+"/slides/slide01.cfm?tk=33;"+_globalRawCSS); aI("text=Achieving Current and Future LDL-C Targets in Daily Practice;url="+_server+"/meetings/daily_practice;"+_globalRawCSS); 
}with(milonic=new menuname("Estrogen")){
style=fourthLevel;
openstyle="rtl";
subimage=scriptpath+"arrow_left.gif";
aI("text=Cardiovascular Disease Outcome During 6.8 Years of Hormone Therapy: Heart and Estrogen/Progestin Replacement Study Follow-Up (HERS II);url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs033;"+_globalRawCSS); aI("text=Risks and Benefits of Estrogen plus Progestin in Healthy Postmenopausal Women;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs034;"+_globalRawCSS); aI("text=Coronary Heart Disease Prediction from Lipoprotein Cholesterol Levels, Triglycerides, Lipoprotein(a), Apolipoproteins A-I and B, and HDL Density Subfractions: The Atherosclerosis Risk in Communities (ARIC) Study;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs020;"+_globalRawCSS); 
}with(milonic=new menuname("Fibric Acid Derivatives")){
style=fourthLevel;
openstyle="rtl";
subimage=scriptpath+"arrow_left.gif";
aI("text=Effect of Fenofibrate on the Progression of Coronary-Artery Disease in Type 2 Diabetes:  The Diabetes Atherosclerosis Intervention Study, a Randomised Study;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs023;"+_globalRawCSS); 
}with(milonic=new menuname("HMG-COA Reductase Inhibitors")){
style=fourthLevel;
openstyle="rtl";
subimage=scriptpath+"arrow_left.gif";
aI("text=Effect of Very High-intensity Statin Therapy on Regression of Coronary Atherosclerosis: The ASTEROID Trial ;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs055;"+_globalRawCSS); aI("text=Management of the Patient with Familial Hypercholesterolemia;url="+_server+"/clinical-cases/hypercholesterolemia;"+_globalRawCSS); aI("text=The Patient with a Statin Intolerance ;url="+_server+"/clinical-cases/statin-intolerance;"+_globalRawCSS); aI("text=The Patient with a Statin Intolerance;url="+_server+"/slides/slide01.cfm?tk=36;"+_globalRawCSS); aI("text=More;url="+_server+"/site/subjects.cfm?sid=29;"+_globalRawCSS); 
}with(milonic=new menuname("Hypoglycemic Agents")){
style=fourthLevel;
openstyle="rtl";
subimage=scriptpath+"arrow_left.gif";
aI("text=Diabetes Prevention Program;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs018;"+_globalRawCSS); aI("text=Clinical Trials and Guidelines for Lipid Management in the Diabetic Patient;url="+_server+"/slides/slide01.cfm?tk=15;"+_globalRawCSS); 
}with(milonic=new menuname("Insulin")){
style=fourthLevel;
openstyle="rtl";
subimage=scriptpath+"arrow_left.gif";
aI("text=Glycemic Control Slows Rates of Carotid Artery Disease Progression;url="+_server+"/commentaries/al_abstract.cfm?abs_id=Abs045;"+_globalRawCSS); 
} with(milonic=new menuname("Apolipoproteins")){
style=fourthLevel;
openstyle="rtl";
subimage=scriptpath+"arrow_left.gif";
aI("text=The Apo A-I Milano Trial;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs047;"+_globalRawCSS); aI("text=Coronary Heart Disease Prediction from Lipoprotein Cholesterol Levels, Triglycerides, Lipoprotein(a), Apolipoproteins A-I and B, and HDL Density Subfractions: The Atherosclerosis Risk in Communities (ARIC) Study;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs020;"+_globalRawCSS); 
}with(milonic=new menuname("HDL")){
style=fourthLevel;
openstyle="rtl";
subimage=scriptpath+"arrow_left.gif";
aI("text=Current and Emerging Pharmacologic Approaches to Targeting HDL;url="+_server+"/slides/slide01.cfm?tk=71;"+_globalRawCSS); aI("text=Evidence to Support Aggressive Management of HDL-C: Implications of Recent Trials;url="+_server+"/slides/slide01.cfm?tk=39;"+_globalRawCSS); aI("text=Combination Lipid-altering Drug Therapy with Statins: An Update;url="+_server+"/slides/slide01.cfm?tk=33;"+_globalRawCSS); aI("text=Cholesterol Metabolism and the Concept of Dual Inhibition;url="+_server+"/slides/slide01.cfm?tk=31;"+_globalRawCSS); aI("text=More;url="+_server+"/site/subjects.cfm?sid=40;"+_globalRawCSS); 
}with(milonic=new menuname("LDL")){
style=fourthLevel;
openstyle="rtl";
subimage=scriptpath+"arrow_left.gif";
aI("text=Reduction of Low-Density Lipoprotein Cholesterol in Patients with Coronary Heart Disease and Metabolic Syndrome: Analysis of the Treating to New Targets (TNT) Study;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs057;"+_globalRawCSS); aI("text=Combination Lipid-altering Drug Therapy with Statins: An Update;url="+_server+"/slides/slide01.cfm?tk=33;"+_globalRawCSS); aI("text=Cholesterol Metabolism and the Concept of Dual Inhibition;url="+_server+"/slides/slide01.cfm?tk=31;"+_globalRawCSS); aI("text=C-Reactive Protein, Metabolic Syndrome, and Cardiovascular Events in Women;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs041;"+_globalRawCSS); aI("text=More;url="+_server+"/site/subjects.cfm?sid=39;"+_globalRawCSS); 
}with(milonic=new menuname("Triglycerides")){
style=fourthLevel;
openstyle="rtl";
subimage=scriptpath+"arrow_left.gif";
aI("text=Cholesterol Metabolism and the Concept of Dual Inhibition;url="+_server+"/slides/slide01.cfm?tk=31;"+_globalRawCSS); aI("text=Influence of Low HDL-C and Elevated Triglyceride on CHD Events and Response to Simvastatin in 4S;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs028;"+_globalRawCSS); 
}with(milonic=new menuname("VLDL")){
style=fourthLevel;
openstyle="rtl";
subimage=scriptpath+"arrow_left.gif";
aI("text=Non-High-Density Lipoprotein Cholesterol as a Predictor of Cardiovascular Disease Mortality;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs017;"+_globalRawCSS); 
} with(milonic=new menuname("Hispanics")){
style=fourthLevel;
openstyle="rtl";
subimage=scriptpath+"arrow_left.gif";
aI("text=Lipid Treatment and Goal Attainment: A Hispanic Male with CHD and Diabetes ;url="+_server+"/clinical-cases/diabetes;"+_globalRawCSS); 
}with(milonic=new menuname("Women")){
style=fourthLevel;
openstyle="rtl";
subimage=scriptpath+"arrow_left.gif";
aI("text=C-Reactive Protein, Metabolic Syndrome, and Cardiovascular Events in Women;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs041;"+_globalRawCSS); aI("text=C-Reactive Protein Levels and Risk for First Cardiovascular Events in Women;url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs037;"+_globalRawCSS); aI("text=Prospective Study of Pravastatin in the Elderly at Risk (PROSPER);url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs038;"+_globalRawCSS); aI("text=Cardiovascular Disease Outcome During 6.8 Years of Hormone Therapy: Heart and Estrogen/Progestin Replacement Study Follow-Up (HERS II);url="+_server+"/commentaries/al_abstract.cfm?abs_id=abs033;"+_globalRawCSS); aI("text=More;url="+_server+"/site/subjects.cfm?sid=47;"+_globalRawCSS); 
} 


drawMenus();